米国の高度創傷ケアOTC市場規模、シェア、動向分析レポート：製品別、用途別、流通チャネル別、セグメント別予測、2025年～2033年

米国の高度創傷ケアOTC市場サマリー

米国の高度創傷ケアOTC市場規模は2024年に27億7,000万米ドルと推計され、2033年には66億1,000万米ドルに達すると予測され、2025年から2033年までのCAGRは10.33%で成長します。成長を牽引しているのは、外科的創傷、外傷、火傷などの急性創傷の増加であり、効果的かつ迅速な創傷管理ソリューションが必要とされています。

世界の交通事故、スポーツ外傷、外科手術の増加により、治癒を早め、感染リスクを低減する高度なOTC創傷ケア製品の需要が急増しています。トータル・ファミリー・ケア・センターが2025年4月に発表したデータによると、米国では年間約1,100万人が急性創傷を経験し、約30万件が病院での治療を必要としています。また、適切な創傷ケアの実践に関する消費者の意識の高まりや、小売薬局やオンラインプラットフォームを通じて高度なドレッシング材を容易に入手できることが、引き続き市場の拡大を支えています。

米国では糖尿病の有病率が高く、増加傾向にあることが市場の成長を大きく後押ししています。糖尿病は慢性創傷、特に糖尿病性足潰瘍を発症する重大な危険因子であり、感染症や切断などの合併症を予防するためにはタイムリーで効果的な創傷管理が必要です。例えば、米国疾病予防管理センター（CDC）の報告によると、3,800万人以上のアメリカ人が糖尿病を患っており（約10人に1人）、そのうち約90％～95％が2型糖尿病です。

軽度の創傷を管理し、創傷の悪化を防ぐことができる、利用しやすい市販の創傷ケア製品への需要が高まっています。先進的なOTC創傷ケア製品は、糖尿病患者に自宅で創傷を治療する便利な方法を提供し、頻繁な受診の必要性を軽減します。このような糖尿病患者のセルフケアに対するニーズの高まりが、米国の高度創傷ケアOTC産業の拡大を後押ししています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 米国の高度創傷ケアOTC市場の変数、動向、および範囲

• 市場系統の見通し
  • 親市場の見通し
  • 補助市場の見通し
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
  • 市場機会分析
  • 市場課題分析
• 米国の高度創傷ケアOTC市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析

第4章 米国の高度創傷ケアOTC市場：製品推定・動向分析

• セグメントダッシュボード
• 米国高度創傷ケアOTC市場変動分析
• 米国高度創傷ケアOTC市場規模と動向分析（製品別、2021～2033年）
• フォームドレッシング
  • 接着剤
  • 非粘着フォームドレッシング
• フィルムドレッシング
• ハイドロコロイド
• ハイドロゲルドレッシング
• ハニードレッシング
• 油っぽいガーゼ
• 不織布術後ドレッシング
• その他

第5章 米国の高度創傷ケアOTC市場：用途の推定・動向分析

• セグメントダッシュボード
• 米国高度創傷ケアOTC市場変動分析
• 米国高度創傷ケアOTC市場規模と動向分析（用途別、2021～2033年）
• 慢性創傷
  • 糖尿病性足潰瘍（ステージ1、ステージ2、ステージ3、ステージ4、深部組織損傷を含む）
  • 褥瘡
  • 静脈性下肢潰瘍
  • その他の慢性創傷
• 急性創傷
  • 外科的創傷および外傷（皮膚裂傷を含む）
  • 火傷

第6章 米国の高度創傷ケアOTC市場：流通チャネルの推定・動向分析

• セグメントダッシュボード
• 米国高度創傷ケアOTC市場変動分析
• 米国高度創傷ケアOTC市場規模と動向分析（流通チャネル別、2021～2033年）
• 小売薬局/ドラッグストア
• Eコマース/オンライン薬局/ 健康関連Eコマース
• その他

第7章 競合情勢

• 市場参入企業の分類
• 主要企業プロファイル
• 企業シェア分析、2024年
  • Smith+Nephew
  • Solventum
  • Molnlycke Health Care AB
  • 3M
  • Convatec Inc.
  • Lavior
  • Vomaris Innovations, Inc.
  • B. Braun SE
  • Coloplast Group
  • PAUL HARTMANN AG
  • Beiersdorf
  • Dimora Medical
  • Remedium Healthcare Products
  • Sonoma Pharmaceuticals, Inc.
  • Cardinal Health
  • DeRoyal Industries, Inc.
  • Medline Industries, LP
  • Lavior

List of Tables

• Table 1. List of Secondary Sources
• Table 2. List of Abbreviations
• Table 3. U.S. Advanced Wound Care OTC Market, by Product, 2021 - 2033 (USD Million)
• Table 4. U.S. Advanced Wound Care OTC Market, by Application, 2021 - 2033 (USD Million)
• Table 5. U.S. Advanced Wound Care OTC Market, by Distribution Channel, 2021 - 2033 (USD Million)
• Table 6. Participant's Overview
• Table 7. Financial Performance
• Table 8. Product Benchmarking
• Table 9. Strategic Initiatives

List of Figures

• Fig. 1 Information Procurement
• Fig. 2 Primary Research Pattern
• Fig. 3 Market Research Approaches
• Fig. 4 Value Chain-Based Sizing & Forecasting
• Fig. 5 Market Formulation & Validation
• Fig. 6 U.S. Advanced Wound Care OTC Market, Market Segmentation
• Fig. 7 Market Driver Analysis (Current & Future Impact)
• Fig. 8 Market Restraint Analysis (Current & Future Impact)
• Fig. 9 Market Opportunity Analysis (Current & Future Impact)
• Fig. 10 Market Challenge Analysis (Current & Future Impact)
• Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 12 Porter's Five Forces Analysis
• Fig. 13 Regional Marketplace: Key Takeaways
• Fig. 14 U.S. Advanced Wound Care OTC Market, for Product, 2021 - 2033 (USD Million)
• Fig. 15 U.S. Advanced Wound Care OTC Market, for Foam Dressings, 2021 - 2033 (USD Million)
• Fig. 16 U.S. Advanced Wound Care OTC Market, for Adhesive, 2021 - 2033 (USD Million)
• Fig. 17 U.S. Advanced Wound Care OTC Market, for Non-adhesive foam dressings, 2021 - 2033 (USD Million)
• Fig. 18 U.S. Advanced Wound Care OTC Market, for Film Dressings, 2021 - 2033 (USD Million)
• Fig. 19 U.S. Advanced Wound Care OTC Market, for Hydrocolloids, 2021 - 2033 (USD Million)
• Fig. 20 U.S. Advanced Wound Care OTC Market, for Hydrogel Dressings, 2021 - 2033 (USD Million)
• Fig. 21 U.S. Advanced Wound Care OTC Market, for Honey Dressings, 2021 - 2033 (USD Million)
• Fig. 22 U.S. Advanced Wound Care OTC Market, for Greasy Gauzes, 2021 - 2033 (USD Million)
• Fig. 23 U.S. Advanced Wound Care OTC Market, for Non-Woven Post Operative Dressings, 2021 - 2033 (USD Million)
• Fig. 24 U.S. Advanced Wound Care OTC Market, for Others, 2021 - 2033 (USD Million)
• Fig. 25 U.S. Advanced Wound Care OTC Market, for Application, 2021 - 2033 (USD Million)
• Fig. 26 U.S. Advanced Wound Care OTC Market, for Chronic Wounds, 2021 - 2033 (USD Million)
• Fig. 27 U.S. Advanced Wound Care OTC Market, for Diabetic Foot Ulcers, 2021 - 2033 (USD Million)
• Fig. 28 U.S. Advanced Wound Care OTC Market, for Pressure Ulcers, 2021 - 2033 (USD Million)
• Fig. 29 U.S. Advanced Wound Care OTC Market, for Venous Leg Ulcers, 2021 - 2033 (USD Million)
• Fig. 30 U.S. Advanced Wound Care OTC Market, for Other Chronic Wounds, 2021 - 2033 (USD Million)
• Fig. 31 U.S. Advanced Wound Care OTC Market, for Acute Wounds, 2021 - 2033 (USD Million)
• Fig. 32 U.S. Advanced Wound Care OTC Market, for Surgical & Traumatic Wounds (skin tears included), 2021 - 2033 (USD Million)
• Fig. 33 U.S. Advanced Wound Care OTC Market, for Burns, 2021 - 2033 (USD Million)
• Fig. 34 U.S. Advanced Wound Care OTC Market, for 1st Degree Burns, 2021 - 2033 (USD Million)
• Fig. 35 U.S. Advanced Wound Care OTC Market, for 2nd Degree Burns, 2021 - 2033 (USD Million)
• Fig. 36 U.S. Advanced Wound Care OTC Market, for 3rd Degree Burns, 2021 - 2033 (USD Million)
• Fig. 37 U.S. Advanced Wound Care OTC Market, for Distribution Channel, 2021 - 2033 (USD Million)
• Fig. 38 U.S. Advanced Wound Care OTC Market, for Retail Pharmacies / Drugstores, 2021 - 2033 (USD Million)
• Fig. 39 U.S. Advanced Wound Care OTC Market, for E-commerce/Online Pharmacies / Health E-tailers, 2021 - 2033 (USD Million)
• Fig. 40 U.S. Advanced Wound Care OTC Market, for Others, 2021 - 2033 (USD Million)

U.S. Advanced Wound Care OTC Market Summary

The U.S. advanced wound care OTC market size was estimated at USD 2.77 billion in 2024 and is projected to reach USD 6.61 billion by 2033, growing at a CAGR of 10.33% from 2025 to 2033. The growth is driven by the increasing prevalence of acute wounds, such as surgical wounds, traumatic injuries, and burns, which require effective and immediate wound management solutions.

Rising rates of road accidents, sports injuries, and surgical procedures globally have led to a surge in demand for advanced OTC wound care products that promote faster healing and reduce the risk of infection. According to the data published by the Total Family Care Center in April 2025, approximately 11 million individuals in the U.S. experience acute wounds annually, with around 300,000 cases requiring hospital care. In addition, the growing awareness among consumers regarding proper wound care practices and the ease of access to advanced dressings through retail pharmacies and online platforms continue to support market expansion.

The high and rising prevalence of diabetes in the U.S. significantly drives the growth of the market. Diabetes is a significant risk factor for the development of chronic wounds, particularly diabetic foot ulcers, which require timely and effective wound management to prevent complications such as infections and amputations. For instance, the Centers for Disease Control and Prevention (CDC) reports that more than 38 million Americans have diabetes (about 1 in 10), and about 90% to 95% of them have type 2 diabetes.

There is an increasing demand for accessible, over-the-counter wound care products that allow individuals to manage minor wounds and prevent them from worsening. Advanced OTC wound care solutions offer diabetic patients a convenient way to treat wounds at home, reducing the need for frequent clinical visits. This growing need for self-care solutions among the diabetic population is a key factor propelling the expansion of the U.S. advanced wound care OTC industry.

U.S. Advanced Wound Care OTC Market Report Segmentation

This report forecasts revenue growth at regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. advanced wound care OTC market report based on product, application, and distribution channel.

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Foam Dressings
  • Adhesive
  • Non-adhesive Foam Dressings
• Film Dressings
• Hydrocolloids
• Hydrogel Dressings
• Honey Dressings
• Greasy Gauzes
• Non-Woven Post Operative Dressings
• Others
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Chronic Wounds
  • Diabetic Foot Ulcers
  • Pressure Ulcers (Stage 1, Stage 2, Stage 3, Stage 4, and Deep Tissue Injury included)
  • Venous Leg Ulcers
  • Other Chronic Wounds
• Acute Wounds
  • Surgical & Traumatic Wounds (skin tears included)
  • Burns
  • 1st degree burns
  • 2nd degree burns
  • 3rd degree burns
• Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
• Retail Pharmacies / Drugstores
• E-commerce/Online Pharmacies / Health E-tailers
• Others

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Application
  • 1.2.3. Distribution Channel
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Advanced Wound Care OTC Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing adoption of digital distribution platforms
    • 3.2.1.2. Rising burden of wounds
    • 3.2.1.3. Increasing approvals for advanced wound care OTC products
    • 3.2.1.4. Rising aging population in the U.S.
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Product recalls
  • 3.2.3. Market Opportunities Analysis
    • 3.2.3.1. Shift from institutional settings to home care
    • 3.2.3.2. Increasing number of road accidents and injuries
    • 3.2.3.3. Expansion opportunity in post-surgical wound management
  • 3.2.4. Market Challenge Analysis
• 3.3. U.S. Advanced Wound Care OTC Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. U.S. Advanced Wound Care OTC Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Advanced Wound Care OTC Market Movement Analysis
• 4.3. U.S. Advanced Wound Care OTC Market Size & Trend Analysis, by Product, 2021 - 2033 (USD Million)
• 4.4. Foam Dressings
  • 4.4.1. Foam Dressings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.2. Adhesive
    • 4.4.2.1. Adhesive Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.3. Non-adhesive Foam Dressings
    • 4.4.3.1. Non-adhesive Foam Dressings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Film Dressings
  • 4.5.1. Film Dressings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Hydrocolloids
  • 4.6.1. Hydrocolloids Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.7. Hydrogel Dressings
  • 4.7.1. Hydrogel Dressings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.8. Honey Dressings
  • 4.8.1. Honey Dressings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.9. Greasy Gauzes
  • 4.9.1. Greasy Gauzes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.10. Non-Woven Post Operative Dressings
  • 4.10.1. Non-Woven Post Operative Dressings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.11. Others
  • 4.11.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Advanced Wound Care OTC Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. Advanced Wound Care OTC Market Movement Analysis
• 5.3. U.S. Advanced Wound Care OTC Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 5.4. Chronic Wounds
  • 5.4.1. Chronic Wounds Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4.2. Diabetic Foot Ulcers (Stage 1, Stage 2, Stage 3, Stage 4 and Deep Tissue Injury included)
    • 5.4.2.1. Diabetic Foot Ulcers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4.3. Pressure Ulcers
    • 5.4.3.1. Pressure Ulcers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4.4. Venous Leg Ulcers
    • 5.4.4.1. Venous Leg Ulcers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4.5. Other Chronic Wounds
    • 5.4.5.1. Other Chronic Wounds Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Acute Wounds
  • 5.5.1. Acute Wounds Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5.2. Surgical & Traumatic Wounds (skin tears included)
    • 5.5.2.1. Surgical & Traumatic Wounds (skin tears included) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5.3. Burns
    • 5.5.3.1. Burns Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.3.2. 1st Degree Burns
      • 5.5.3.2.1. 1st Degree Burns Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.3.3. 2nd Degree Burns
      • 5.5.3.3.1. 2nd Degree Burns Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.3.4. 3rd Degree Burns
      • 5.5.3.4.1. 3rd Degree Burns Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Advanced Wound Care OTC Market: Distribution Channel Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. U.S. Advanced Wound Care OTC Market Movement Analysis
• 6.3. U.S. Advanced Wound Care OTC Market Size & Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
• 6.4. Retail Pharmacies / Drugstores
  • 6.4.1. Retail Pharmacies / Drugstores Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. E-commerce/Online Pharmacies / Health E-tailers
  • 6.5.1. E-commerce/Online Pharmacies / Health E-tailers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Others
  • 6.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Market Participant Categorization
• 7.2. Key Company Profiles
• 7.3. Company Share Analysis, 2024
  • 7.3.1. Smith+Nephew
    • 7.3.1.1. Company Overview
    • 7.3.1.2. Financial Performance
    • 7.3.1.3. Product Benchmarking
    • 7.3.1.4. Strategic Initiatives
  • 7.3.2. Solventum
    • 7.3.2.1. Company Overview
    • 7.3.2.2. Financial Performance
    • 7.3.2.3. Product Benchmarking
    • 7.3.2.4. Strategic Initiatives
  • 7.3.3. Molnlycke Health Care AB
    • 7.3.3.1. Company Overview
    • 7.3.3.2. Financial Performance
    • 7.3.3.3. Product Benchmarking
    • 7.3.3.4. Strategic Initiatives
  • 7.3.4. 3M
    • 7.3.4.1. Company Overview
    • 7.3.4.2. Financial Performance
    • 7.3.4.3. Product Benchmarking
    • 7.3.4.4. Strategic Initiatives
  • 7.3.5. Convatec Inc.
    • 7.3.5.1. Company Overview
    • 7.3.5.2. Financial Performance
    • 7.3.5.3. Product Benchmarking
    • 7.3.5.4. Strategic Initiatives
  • 7.3.6. Lavior
    • 7.3.6.1. Company Overview
    • 7.3.6.2. Financial Performance
    • 7.3.6.3. Product Benchmarking
    • 7.3.6.4. Strategic Initiatives
  • 7.3.7. Vomaris Innovations, Inc.
    • 7.3.7.1. Company Overview
    • 7.3.7.2. Financial Performance
    • 7.3.7.3. Product Benchmarking
    • 7.3.7.4. Strategic Initiatives
  • 7.3.8. B. Braun SE
    • 7.3.8.1. Company Overview
    • 7.3.8.2. Financial Performance
    • 7.3.8.3. Product Benchmarking
    • 7.3.8.4. Strategic Initiatives
  • 7.3.9. Coloplast Group
    • 7.3.9.1. Company Overview
    • 7.3.9.2. Financial Performance
    • 7.3.9.3. Product Benchmarking
    • 7.3.9.4. Strategic Initiatives
  • 7.3.10. PAUL HARTMANN AG
    • 7.3.10.1. Company Overview
    • 7.3.10.2. Financial Performance
    • 7.3.10.3. Product Benchmarking
    • 7.3.10.4. Strategic Initiatives
  • 7.3.11. Beiersdorf
    • 7.3.11.1. Company Overview
    • 7.3.11.2. Financial Performance
    • 7.3.11.3. Product Benchmarking
    • 7.3.11.4. Strategic Initiatives
  • 7.3.12. Dimora Medical
    • 7.3.12.1. Company Overview
    • 7.3.12.2. Financial Performance
    • 7.3.12.3. Product Benchmarking
    • 7.3.12.4. Strategic Initiatives
  • 7.3.13. Remedium Healthcare Products
    • 7.3.13.1. Company Overview
    • 7.3.13.2. Financial Performance
    • 7.3.13.3. Product Benchmarking
    • 7.3.13.4. Strategic Initiatives
  • 7.3.14. Sonoma Pharmaceuticals, Inc.
    • 7.3.14.1. Company Overview
    • 7.3.14.2. Financial Performance
    • 7.3.14.3. Product Benchmarking
    • 7.3.14.4. Strategic Initiatives
  • 7.3.15. Cardinal Health
    • 7.3.15.1. Company Overview
    • 7.3.15.2. Financial Performance
    • 7.3.15.3. Product Benchmarking
    • 7.3.15.4. Strategic Initiatives
  • 7.3.16. DeRoyal Industries, Inc.
    • 7.3.16.1. Company Overview
    • 7.3.16.2. Financial Performance
    • 7.3.16.3. Product Benchmarking
    • 7.3.16.4. Strategic Initiatives
  • 7.3.17. Medline Industries, LP
    • 7.3.17.1. Company Overview
    • 7.3.17.2. Financial Performance
    • 7.3.17.3. Product Benchmarking
    • 7.3.17.4. Strategic Initiatives
  • 7.3.18. Lavior
    • 7.3.18.1. Company Overview
    • 7.3.18.2. Financial Performance
    • 7.3.18.3. Product Benchmarking
    • 7.3.18.4. Strategic Initiatives